{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T18:08:09Z","timestamp":1782151689023,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.mvr.2014.05.009","type":"journal-article","created":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T05:32:19Z","timestamp":1402291939000},"page":"106-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["In vitro and in vivo anti-angiogenic effects of hydroxyurea"],"prefix":"10.1016","volume":"94","author":[{"given":"Fl\u00e1via Cristine Mascia","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regiane","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulcin\u00e9ia Martins","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lica A. Antoniellis","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Ferreira","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5726-7919","authenticated-orcid":false,"given":"Nicola","family":"Conran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mvr.2014.05.009_bb0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-3-642-67729-8_49","article-title":"Hydroxyurea as a reference standard in teratological screening. Comparison of the embryotoxic and teratogenic effects following single intraperitoneal or repeated oral administrations to pregnant rats","volume":"4","author":"Aliverti","year":"1980","journal-title":"Arch. Toxicol. Suppl."},{"key":"10.1016\/j.mvr.2014.05.009_bb0010","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1182\/blood-2009-04-217950","article-title":"Placenta growth factor in sickle cell disease: association with hemolysis and inflammation","volume":"115","author":"Brittain","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2014.05.009_bb0015","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V79.10.2555.2555","article-title":"Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia","volume":"79","author":"Charache","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2014.05.009_bb0020","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2014.05.009_bb0025","doi-asserted-by":"crossref","first-page":"G5","DOI":"10.1152\/ajpgi.00107.2007","article-title":"Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues","volume":"293","author":"Chidlow","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0030","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.clinbiochem.2009.06.024","article-title":"Hemoglobin disorders and endothelial cell interactions","volume":"42","author":"Conran","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.mvr.2014.05.009_bb0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10456-007-9074-0","article-title":"Angiogenesis and chronic inflammation: cause or consequence?","volume":"10","author":"Costa","year":"2007","journal-title":"Angiogenesis"},{"key":"10.1016\/j.mvr.2014.05.009_bb5000","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/03630269.2013.789968","article-title":"Leg ulcers in sickle cell disease: current patterns and practices","volume":"37","author":"Delaney","year":"2013","journal-title":"Hemoglobin"},{"key":"10.1016\/j.mvr.2014.05.009_bb0040","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1182\/blood.V99.9.3144","article-title":"Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events","volume":"99","author":"Dobson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2014.05.009_bb0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2141.2006.06103.x","article-title":"Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease","volume":"134","author":"Duits","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-291X(68)90266-0","article-title":"Effect of hydroxyurea on ribonucleotide reductase","volume":"33","author":"Elford","year":"1968","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mvr.2014.05.009_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.mvr.2014.05.009_bb0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"Folkman","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mvr.2014.05.009_bb0065","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clinbiochem.2006.09.012","article-title":"Distinct modulation of alkaline phosphatase isoenzymes by 17beta-estradiol and xanthohumol in breast cancer MCF-7 cells","volume":"40","author":"Guerreiro","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.mvr.2014.05.009_bb0070","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/humupd\/4.5.736","article-title":"Angiogenesis: a new theory for endometriosis","volume":"4","author":"Healy","year":"1998","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.mvr.2014.05.009_bb0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1871529X10909040271","article-title":"A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis","volume":"9","author":"Hebbel","year":"2009","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"10.1016\/j.mvr.2014.05.009_bb0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1096\/fasebj.11.6.9194526","article-title":"The codependence of angiogenesis and chronic inflammation","volume":"11","author":"Jackson","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/j.mvr.2014.05.009_bb0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncponc0403","article-title":"Lessons from phase III clinical trials on anti-VEGF therapy for cancer","volume":"3","author":"Jain","year":"2006","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/alzrt230","article-title":"Adjusting the compass: new insights into the role of angiogenesis in Alzheimer's disease","volume":"5","author":"Jefferies","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.mvr.2014.05.009_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato","year":"2007","journal-title":"Blood Rev."},{"key":"10.1016\/j.mvr.2014.05.009_bb6000","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ajh.1183","article-title":"Hydroxyurea and sickle cell leg ulcers","volume":"68","author":"Kersgard","year":"2001","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0014-4835(03)00174-X","article-title":"Expression of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in sickle cell retina and choroid","volume":"77","author":"Kim","year":"2003","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mvr.2014.05.009_bb0105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.freeradbiomed.2004.02.073","article-title":"Nitric oxide production from hydroxyurea","volume":"37","author":"King","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mvr.2014.05.009_bb0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrrheum.2011.205","article-title":"Hypoxia\u2014a key regulator of angiogenesis and inflammation in rheumatoid arthritis","volume":"8","author":"Konisti","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0115","doi-asserted-by":"crossref","first-page":"515-23","DOI":"10.1097\/00054725-200606000-00012","article-title":"Role of angiogenesis in inflammatory bowel disease","volume":"12","author":"Koutroubakis","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.mvr.2014.05.009_bb0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mehy.2010.08.023","article-title":"Hydroxyurea (therapeutics and mechanism): metabolism, carbamoyl nitroso, nitroxyl, radicals, cell signaling and clinical applications","volume":"76","author":"Kovacic","year":"2011","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mvr.2014.05.009_bb0125","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.2741\/3167","article-title":"Angiogenesis and inflammation in carotid atherosclerosis","volume":"13","author":"Krupinski","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.mvr.2014.05.009_bb0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000243727","article-title":"Elevated circulating stromal-derived factor-1 levels in sickle cell disease","volume":"122","author":"Landburg","year":"2009","journal-title":"Acta Haematol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/FPC.0b013e32833854d6","article-title":"Hydroxycarbamide stimulates the production of proinflammatory cytokines by endothelial cells: relevance to sickle cell disease","volume":"20","author":"Laurance","year":"2010","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.mvr.2014.05.009_bb0140","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3324\/haematol.2010.023325","article-title":"Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model","volume":"95","author":"Lebensburger","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.mvr.2014.05.009_bb0145","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.377.377","article-title":"Proangiogenic effects of plasma from sickle cell disease patients and antiangiogenic effects of hydroxyurea: evaluation of invasion and proliferation of human endothelial cells and effects of hydroxyurea in a mouse Matrigel plug neovascularization assay","volume":"120","author":"Lopes","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2014.05.009_bb0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/08880018.2013.876471","article-title":"Serum angiogenin level in sickle cell disease and beta thalassemia patients","volume":"31","author":"Matter","year":"2014","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MOH.0b013e32834521dd","article-title":"Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?","volume":"18","author":"McGann","year":"2011","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0160","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2141.2009.07726.x","article-title":"Angiogenesis and vascular endothelial growth factor-\/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status","volume":"146","author":"Medinger","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0165","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ajh.21838","article-title":"Leg ulcers in sickle cell disease","volume":"85","author":"Minniti","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0170","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ajh.22065","article-title":"Laboratory and echocardiography markers in sickle cell patients with leg ulcers","volume":"86","author":"Minniti","year":"2011","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568010053622830","article-title":"Role of inflammatory mediators in angiogenesis","volume":"4","author":"Naldini","year":"2005","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"10.1016\/j.mvr.2014.05.009_bb0180","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/jcb.22850","article-title":"Angiogenesis and inflammation signaling are targets of beer polyphenols on vascular cells","volume":"111","author":"Negrao","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.mvr.2014.05.009_bb0185","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ajh.22274","article-title":"Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates","volume":"87","author":"Novelli","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0190","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1167\/iovs.07-1527","article-title":"Differential suppression of vascular permeability and corneal angiogenesis by nonsteroidal anti-inflammatory drugs","volume":"49","author":"Pakneshan","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mvr.2014.05.009_bb0195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.vph.2006.01.005","article-title":"Angiogenesis\u2014a new target for future therapy","volume":"44","author":"Pandya","year":"2006","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0200","doi-asserted-by":"crossref","first-page":"16713","DOI":"10.1074\/jbc.M110.101691","article-title":"Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD)","volume":"285","author":"Patel","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mvr.2014.05.009_bb0205","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1182\/blood-2006-01-012369","article-title":"MicroRNAs modulate the angiogenic properties of HUVECs","volume":"108","author":"Poliseno","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2014.05.009_bb0210","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1365-2222.2009.03385.x","article-title":"Angiogenesis in asthma","volume":"39","author":"Ribatti","year":"2009","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.mvr.2014.05.009_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.exger.2011.10.004","article-title":"MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation","volume":"47","author":"Rippe","year":"2012","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0220","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0149-2918(08)80057-4","article-title":"Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject","volume":"30","author":"Saraceno","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.mvr.2014.05.009_bb0225","doi-asserted-by":"crossref","first-page":"26616","DOI":"10.1074\/jbc.M111.224212","article-title":"Heparin impairs angiogenesis through inhibition of microRNA-10b","volume":"286","author":"Shen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mvr.2014.05.009_bb7000","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1001\/archderm.135.7.818","article-title":"Leg ulcers and hydroxyurea: forty-one cases","volume":"135","author":"Sirieix","year":"1999","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.mvr.2014.05.009_bb9000","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1210\/me.2003-0362","article-title":"Evidence for the notch signaling pathway on the role of estrogen in angiogenesis","volume":"18","author":"Soares","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0235","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/CIRCRESAHA.108.191270","article-title":"MicroRNAs as novel regulators of angiogenesis","volume":"104","author":"Suarez","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2014.05.009_bb0230","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.RES.0000265065.26744.17","article-title":"Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells","volume":"100","author":"Suarez","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2014.05.009_bb0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood-2009-09-244830","article-title":"High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension","volume":"116","author":"Sundaram","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2014.05.009_bb0245","series-title":"Encyclopedia of the Eye","article-title":"Angiogenesis in inflammation","author":"Szekanecz","year":"2010"},{"key":"10.1016\/j.mvr.2014.05.009_bb0250","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3109\/10428194.2010.500435","article-title":"Plasma levels of angiogenic factors and circulating endothelial cells in essential thrombocythemia: correlation with cytoreductive therapy and JAK2-V617F mutational status","volume":"51","author":"Trelinski","year":"2010","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.mvr.2014.05.009_bb0255","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.4161\/cc.5.21.3422","article-title":"miRNAs regulate miRNAs: coordinated transcriptional and post-transcriptional regulation","volume":"5","author":"Tuccoli","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.mvr.2014.05.009_bb0260","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/13894501113149990015","article-title":"Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases","volume":"14","author":"Vadlapatla","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.mvr.2014.05.009_bb0265","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/j.1552-4604.1996.tb04176.x","article-title":"Pharmacokinetics of hydroxyurea in patients infected with human immunodeficiency virus type I","volume":"36","author":"Villani","year":"1996","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0270","article-title":"Advances in the use of hydroxyurea","volume":"62\u20139","author":"Ware","year":"2009","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"10.1016\/j.mvr.2014.05.009_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.etp.2004.04.011","article-title":"Effects of prenatal hydroxyurea-treatment on mouse offspring","volume":"56","author":"Woo","year":"2004","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.mvr.2014.05.009_bb0280","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbrc.2012.12.157","article-title":"Increased expression of microRNA-221 inhibits PAK1 in endothelial progenitor cells and impairs its function via c-Raf\/MEK\/ERK pathway","volume":"431","author":"Zhang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286214000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286214000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T01:49:38Z","timestamp":1649296178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286214000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":60,"alternative-id":["S0026286214000867"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2014.05.009","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo anti-angiogenic effects of hydroxyurea","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2014.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}